Skip to content
Research Article Open access CC BY 3.0

In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells

Luciana Petti, Francesca De Santis, Stefania Vetrano

European Journal of Medicinal Plants · pp. 1022–1035 · Published 7 Jun 2014

10.9734/EJMP/2014/11018

Abstract

Aim: To define the putative anti-inflammatory and cytotoxic effects of ibidì®, a new phytotherapeutic formulation composed of three extracts: Punica granatum L, pericarpum; Boswellia serrata Roxb., resina; Curcuma longa L,. rhizome, using Caco-2 cells, an in vitro model of human intestinal epithelium. Methodology: cytotoxicity and capacity of ibidì® to induce cell proliferation were assessed respectively by 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide (XTT) assay and nucleotide 5-bromo-2’-deoxyuridine (BrdU) incorporation. Cell migration was evaluated by scratch wound assay. COX-2, IL-6, IL-8 and MCP-1 protein levels were measured in the supernatant of cells stimulated with or without TNF-alfa or IL-1 beta in presence or in absence of ibidì® using ELISA assays. Finally, the influence of ibidì® on the integrity, paracellular permeability, and viability of Caco-2 cell monolayers was monitored by measuring the transepithelial electrical resistance (TEER) in presence or in absence of TNF-a stimulation. Results: No dose-response toxicity was observed after 48 h incubation with ibidì®. Interestingly the cell proliferation rate was generally lower in presence of ibidì® than vehicle at all concentrations tested, while ibidì® had no effects on cell migration. Ibidì® markedly inhibited TNF-alfa-induced production of IL-8 at all concentrations tested in a dose-response manner, while that of IL-6 and MCP-1 only at highest ibidì® concentrations. Importantly ibidì® in a range of concentration between 145 and 9 µg/ml not only abrogated TNF-alfa-dependent TEER depression, but also promoted higher resistance values than untreated cells. Conclusion: These data demonstrate that ibidì® exerts anti-inflammatory and protective effects on intestinal epithelial cells by blocking the production of IL-8, IL-6 and MCP-1, and unveil that the synergism of the three extracts regulates epithelial barrier function.  

Punica granatum pericarpium Curcuma longa Boswellia serrata epithelial barrier function trans-epithelial resistance

References (32)

  1. 1 Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication [DOI]
  2. 2 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
  3. 3 The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics [DOI]
  4. 4 Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial [DOI]
  5. 5 Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex [DOI]
  6. 6 Therapeutic applications of pomegranate (Punica granatum L.): a review.
  7. 7 The double-blind, randomized, placebo-controlled trial [DOI]
  8. 8 Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study [DOI]
  9. 9 Synergy effects of herb extracts: Pharmacokinetics and pharmacodynamic basis [DOI]
  10. 10 Effects of Gum Resin of Boswellia serrata in Patients with Chronic Colitis [DOI]
  11. 11 Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice [DOI]
  12. 12 Effects of Boswellia serrata gum resin in patients with ulcerative colitis.
  13. 13 The Bioactivity of Pomegranate: Impact on Health and Disease [DOI]
  14. 14 Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats [DOI]
  15. 15 Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials [DOI]
  16. 16 Effect of Boswellia serrata on Antioxidant Status in an Experimental Model of Colitis Rats Induced by Acetic Acid [DOI]
  17. 17 Clinically based evidence of drug–herb interactions: a systematic review [DOI]
  18. 18 A Review on the Anti-Inflammatory Activity of Pomegranate in the Gastrointestinal Tract [DOI]
  19. 19 Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis [DOI]
  20. 20 Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis [DOI]
  21. 21 Antiplasmodial activity of Punica granatum L. fruit rind [DOI]
  22. 22 Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial [DOI]
  23. 23 Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells [DOI]
  24. 24 Effects ofBoswellia serratain mouse models of chemically induced colitis [DOI]
  25. 25 Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy [DOI]
  26. 26 Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome [DOI]
  27. 27 Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation [DOI]
  28. 28 Anti-inflammatory effects of pomegranate (Punica granatum L.) husk ellagitannins in Caco-2 cells, an in vitro model of human intestine [DOI]
  29. 29 Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium [DOI]
  30. 30 Chemokines in inflammatory bowel disease [DOI]
  31. 31 Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis [DOI]
  32. 32 Effect of Punica granatum fruits in inflammatory bowel disease.

Cited by 4

Boswellia Carries Hope for Patients with Inflammatory Bowel Disease (IBD)

Sally Elnawasany · Medicinal Plants - Chemical, Biochemical, and Pharmacological Approaches · 2024

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

10

Page views

0

PDF downloads

0

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.